Company Analysis

Actinium Pharmaceuticals, Inc (ATNM)

NYSE: ATNM · Pharmaceutical Preparations · New York, NY · filing with the SEC since 2007
Grade4.3
◀ Past 3.5● Present 3.7▶ Future 5.2
1 est.

Filings

192 filings since 2017 beside 97 insider forms · Non-accelerated filer and smaller reporting company · read from EDGAR on Nov 13, 2026
Due nextNon-accelerated filer and smaller reporting company
10-Q Quarterly report for the quarter ending Sep 30, 2026Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by Nov 14, 2026
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. The proxy statement was last filed Oct 15, 2026.

Filings a yearinsider forms included
2944172118211822
20192020202120222023202420252026

2026 counts to Nov 13, 2026.

Officer or director change (8-K item 5.02): 6 times in the last 36 months, the newest Oct 15, 2026.Listing warning from its exchange (8-K item 3.01): 2 times in the last 36 months, the newest Aug 14, 2026.Auditor change (8-K item 4.01): 1 time in the last 36 months, the newest May 9, 2025.SEC letters: 1 in the last 36 months, the newest Feb 2, 2024.
Insider forms 97

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Oct 15, 2026 ARS Annual report to shareholders Dec 31, 2025
Oct 15, 2026 DEF 14A Proxy statement Nov 25, 2026
Oct 15, 2026 8-K items 5.02, 7.01, 9.01 Officer or director change; Investor disclosure (Regulation FD) · Current report Oct 14, 2026
Oct 9, 2026 S-8 Employee stock plan registration
Aug 14, 2026 8-K items 3.01, 7.01, 9.01 Listing warning from its exchange; Investor disclosure (Regulation FD) · Current report Aug 12, 2026
Aug 7, 2026 10-Q Quarterly report Jun 30, 2026
Jun 18, 2026 8-K item 8.01 Other event · Current report
May 29, 2026 8-K items 3.01, 7.01, 9.01 Listing warning from its exchange; Investor disclosure (Regulation FD) · Current report May 27, 2026
May 8, 2026 10-Q Quarterly report Mar 31, 2026
Mar 30, 2026 10-K Annual report Dec 31, 2025
Mar 26, 2026 8-K/A item 5.07 Shareholder vote · Current report, amended Nov 26, 2025
Feb 13, 2026 8-K item 5.02 Officer or director change · Current report Feb 11, 2026
Nov 26, 2025 8-K items 5.02, 5.07 Officer or director change; Shareholder vote · Current report
Nov 14, 2025 10-Q Quarterly report Sep 30, 2025
Nov 5, 2025 ARS Annual report to shareholders Dec 31, 2024
Nov 5, 2025 DEF 14A Proxy statement Nov 26, 2025
Aug 8, 2025 10-Q Quarterly report Jun 30, 2025
Jul 29, 2025 SCHEDULE 13G/A Large holder update, amended
Jul 16, 2025 SCHEDULE 13G/A Large holder update, amended
May 9, 2025 10-Q Quarterly report Mar 31, 2025
May 9, 2025 8-K items 4.01, 9.01 Auditor change · Current report May 8, 2025
Mar 31, 2025 10-K Annual report Dec 31, 2024
Nov 27, 2024 8-K items 5.02, 5.07 Officer or director change; Shareholder vote · Current report
Nov 14, 2024 10-Q Quarterly report Sep 30, 2024
Nov 12, 2024 SC 13G/A Large holder update, amended
Nov 8, 2024 SC 13G/A Large holder update, amended
Nov 6, 2024 ARS Annual report to shareholders Dec 31, 2023
Nov 5, 2024 8-K items 5.02, 8.01, 9.01 Officer or director change; Other event · Current report Nov 1, 2024
Nov 5, 2024 DEF 14A Proxy statement Nov 27, 2024
Nov 4, 2024 SC 13G/A Large holder update, amended
Nov 4, 2024 SC 13G Large holder notice
Aug 5, 2024 10-Q Quarterly report Jun 30, 2024
Aug 5, 2024 8-K items 7.01, 9.01 Investor disclosure (Regulation FD) · Current report
Apr 26, 2024 10-Q Quarterly report Mar 31, 2024
Mar 29, 2024 S-8 Employee stock plan registration
Mar 29, 2024 10-K Annual report Dec 31, 2023
Feb 9, 2024 SC 13G/A Large holder update, amended
Feb 5, 2024 EFFECT Registration effective
Feb 2, 2024 CORRESP Reply to the SEC
Feb 2, 2024 S-3/A Shelf registration, amended
40 of 192 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton ATNM · research, not advice